Beta Glucan Market Size

Beta Glucan Market Analysis

The Beta Glucan Market size is estimated at USD 602.54 million in 2024, and is expected to reach USD 881.64 million by 2029, growing at a CAGR of 7.91% during the forecast period (2024-2029).

COVID-19 pandemic is still transforming the growth of numerous industries, the outbreak's immediate impact is varied. While some sectors may experience a decline in demand, many others continue to stay unaffected and exhibit strong development prospects. The global beta-glucan market has been witnessing significant growth due to the increasing health and hygiene consciousness among consumers globally, owing to the impact of the COVID-19 pandemic. Consumers have grown more mindful of their health and proactive about maintaining it through healthy living. As a result, consumer demand has shifted from processed food to nutritious, low-calorie, non-oily, functional, and superfoods. Consumers have become more conscious of food ingredients and pay close attention to nutrition labels and product contents. This shift in consumer behavior has increased demand for healthy foods and supplements, prompting various producers to introduce new functional, non-genetically modified, and naturally produced food products.Furthermore, changing lifestyles, recovering economies, and shift toward natural products have been observed in developing economies, leading to the growth in demand for beta-glucan, not only in food & beverage, personal care, and pharmaceutical products but also in other industrial applications, including animal feed, cosmetics, and biofuel production.

Over the long term,Beta-glucans are biologically active fibers derived from the cell wall of various natural sources, including yeast, mushroom, oats, barley, and others, with the proven benefits for health and medical significance. The beta-glucans are allowed in several countries, including the United States, Canada, Finland, Sweden, China, Japan, and Korea, as potent immunological activators. Beta-glucans are not synthesized by the human bod. Hence, these are recognized by the immune system, and these induce both adaptive and innate immune responses.Currently, the available beta-glucan is sold for providing health benefits, such as the wellness of the cardiac system, immune system, digestive system, and others. For example, Leiber GmbH, a German manufacturer, offers a varied range of specialized yeast products, including Yestimun. Yestimun is an 85% pure beta-glucan derived from brewer's yeast. Beta-glucan is used for digestive health by triggering an immune-modulating response.Some of the players operating in the beta-glucan market are Tate & Lyle PLC, Kerry Group PLC, Koninklijke DSM NV, Super Beta-Glucan, Lantmännen, among others.